Literature DB >> 2608080

Survival prediction in amyotrophic lateral sclerosis.

C K Jablecki1, C Berry, J Leach.   

Abstract

This longitudinal study of 194 patients with sporadic ALS demonstrated that it is possible for physicians to predict the approximate survival time for an individual ALS patient given: (1) the age of the patient, (2) the duration of his weakness and (3) an estimate of his clinical disability (ALS Score). This information is of value in the clinical management of ALS patients, and it should facilitate construction of experimental therapeutic trials in ALS.

Entities:  

Mesh：

Year:  1989        PMID： 2608080     DOI： 10.1002/mus.880121008

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


  16 in total

1.  Amyotrophic Lateral Sclerosis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

2.  The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group III.

Authors:  V Meininger; M Dib; F Aubin; G Jourdain; P Zeisser
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

3.  Amyotrophic lateral sclerosis: Ethical challenges.

Authors: 
Journal:  Neurol Clin Pract       Date:  2011-12

4.  Amyotrophic lateral sclerosis: early predictors of prolonged survival.

Authors:  Adam Czaplinski; Albert A Yen; Stanley H Appel
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

5.  Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis.

Authors:  R P Bruyn; J H Koelman; D Troost; J M de Jong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

6.  An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis.

Authors:  L Mazzini; D Testa; C Balzarini; G Mora
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

Review 7.  Physical activity and neuroprotection in amyotrophic lateral sclerosis.

Authors:  Mary E McCrate; Brian K Kaspar
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

8.  The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register.

Authors:  A M Chancellor; J M Slattery; H Fraser; R J Swingler; S M Holloway; C P Warlow
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

9.  Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.

Authors:  Kim Traxinger; Crystal Kelly; Brent A Johnson; Robert H Lyles; Jonathan D Glass
Journal:  Neurol Clin Pract       Date:  2013-08

Review 10.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.